Lorbrena and Stools - watery - a phase IV clinical study of FDA data

Summary:

Stools - watery is reported as a side effect among people who take Lorbrena (lorlatinib), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Etoposide, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Stools - watery when taking Lorbrena. It is created by eHealthMe based on reports of 2,148 people who have side effects when taking Lorbrena from the FDA, and is updated regularly.

What is Lorbrena?

Lorbrena has active ingredients of lorlatinib. eHealthMe is studying from 2,148 Lorbrena users. Check the latest studies of Lorbrena.

What is Stools - watery?

Stools - watery is found to be associated with 4,681 drugs and 5,938 conditions by eHealthMe. Check the latest studies of Stools - watery.

On Jul, 16, 2026

2,148 people reported to have side effects when taking Lorbrena.
Among them, 39 people (1.82%) have Stools - watery.

Among these 39 people:

How long have people been on Lorbrena when they have Stools - watery? *

What is the gender of people who have Stools - watery when taking Lorbrena? *

female: 51.35 %
male: 48.65 %

What is the age of people who have Stools - watery when taking Lorbrena? *

What are other drugs people take besides Lorbrena? *

Unituxin: 4 people, 10.26%
Cyclophosphamide: 4 people, 10.26%
Etoposide: 4 people, 10.26%
Zolpidem: 3 people, 7.69%
Crestor: 3 people, 7.69%
Topotecan Hydrochloride: 3 people, 7.69%
Nexium: 3 people, 7.69%
Tobramycin And Dexamethasone: 2 people, 5.13%
Xalkori: 2 people, 5.13%
Ibuprofen: 1 person, 2.56%

What are other side effects people have besides Stools - watery? *

Neoplasm Progression (growth of tumour): 10 people, 25.64%
Dyspnea (difficult or laboured breathing): 6 people, 15.38%
Pneumonia: 5 people, 12.82%
Fatigue (feeling of tiredness): 5 people, 12.82%
Stress Cardiomyopathy (stress-induced chronic disease of the heart muscle): 5 people, 12.82%
Stress And Anxiety: 4 people, 10.26%
Gastrointestinal Toxicity (damage to digestive tract by any substance): 4 people, 10.26%
Rashes (redness): 4 people, 10.26%
Oedema Peripheral (superficial swelling): 4 people, 10.26%
Immunodeficiency Disorders: 4 people, 10.26%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 11 people, 28.21%
Lung Neoplasm Malignant (cancer tumour of lung): 11 people, 28.21%
Neuroblastoma Recurrent (reoccurrence of a cancer that forms in your nerve tissue): 4 people, 10.26%
Neuroblastoma (a cancer that forms in your nerve tissue): 4 people, 10.26%
Insomnia (sleeplessness): 3 people, 7.69%
Dyslipidaemia (abnormal amount of lipids): 3 people, 7.69%
Back Pain: 3 people, 7.69%
Gastric Ulcer (stomach ulcer): 3 people, 7.69%
Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 2 people, 5.13%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Lorbrena and have Stools - watery?

- Check whether Stools - watery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lorbrena:

Lorbrena (2,148 reports)

Stools - watery treatments and more:

Stools - watery (756,290 reports)

Browse all side effects of Lorbrena:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stools - watery:

Stools - watery (4,681 drugs)

Browse all the conditions that are associated with Stools - watery:

Stools - watery (5,938 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorlatinib (the active ingredients of Lorbrena) and Lorbrena (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.